Radiation Therapy Devices by Multidata Systems International: Discontinue Use – Concerns about Risks to PatientsAUDIENCE: Risk Manager, Oncology, Radiology ISSUE: The FDA is concerned about the risks to patients from the use of devices manufactured and sold by Multidata Systems International Corporation ("Multidata"). The FDA knows of at least two Multidata medical devices that the company manufactured and distributed in the United States for which FDA never received nor reviewed 510(k) premarket notifications. These devices include: (1) accessories to radiation therapy devices including the Real Time Dosimetry (RTD) Waterphantom System and (2) the Dual Channel Electrometer. In addition, Multidata has not registered or listed their devices with the FDA, as required by federal law. The FDA is concerned that health care providers may be unaware of the risks associated with these devices. At this time, it is not known how many devices manufactured by Multidata are currently in use in hospitals and clinics throughout the United States. The FDA is not aware of adverse event reports associated with the use of Multidata's devices since Multidata has been under the Decree. BACKGROUND: Since 2003, Multidata has been under a Consent Decree of Permanent Injunction (the "Decree") entered by the U.S. District Court for the Eastern District of Missouri (civil action no. 4:03cv575). The Decree prohibits Multidata from designing, manufacturing, processing, and distributing medical devices, among other restrictions. The FDA has learned, however, that Multidata manufactured and distributed medical devices in violation of the Decree, including repairing and exchanging Waterphantom devices for newer design models. RECOMMENDATIONS:
Read the MedWatch safety alert, including a link to the FDA Letter to Healthcare Providers, at: |